AUS
NZ
UK
CA
USA
IND
Beyond Air, Inc. (NASDAQ:XAIR), a pioneering company in the medical device and biopharmaceutical sector, is making waves in neonatal healthcare by deploying its state-of-the-art LungFit® PH system at the U.S. Naval Hospital Guam. This initiative, achieved in collaboration with TrillaMed, is set to revolutionize the care provided to newborns facing respiratory challenges, particularly those suffering from persistent pulmonary hypertension.
The LungFit® PH system stands out as a groundbreaking device engineered to produce nitric oxide (NO) directly from ambient air. Nitric oxide is crucial in treating persistent pulmonary hypertension in neonates (PPHN), a serious condition affecting newborns' lungs and hearts. By providing a safe, effective, and user-friendly solution, the LungFit® PH ensures that vulnerable patients receive the highest standard of care during critical moments.
- Its lightweight and space-efficient design makes it ideal for intensive care settings, allowing for easy transportation within the hospital.
- The system’s ability to generate NO without relying on high-pressure cylinders enhances safety and ease of use in critical environments.
- The LungFit® PH delivers quick results, improving oxygenation for neonates suffering from PPHN, which can be life-saving during emergencies.
- The device can be easily incorporated into the existing infrastructure of hospitals, ensuring minimal disruption while maximizing benefits.
Steve Lisi, CEO of Beyond Air, expressed pride in supporting the U.S. Naval Hospital Guam’s mission to provide exceptional neonatal care. “Through our partnership with TrillaMed, we are able to extend the reach of our LungFit® PH, delivering critical solutions to the healthcare community. This collaboration is a testament to our commitment to advancing neonatal care and improving patient outcomes,” Lisi stated.
The U.S. Naval Hospital Guam is a vital healthcare provider for the military community in the region. Currently, over 17,000 active-duty personnel and their families are stationed on Guam, with an expected increase of 2,500 in the coming two years. The hospital sees an average of 315 births annually, with projections suggesting that this number could rise to 487 by 2033.
The introduction of the LungFit® PH system reinforces the hospital’s dedication to utilizing cutting-edge technologies in neonatal care. By ensuring military families have access to the latest respiratory treatment options, Beyond Air is playing a crucial role in enhancing health outcomes for some of the most vulnerable patients.
Beyond Air’s deployment of the LungFit® PH system at the U.S. Naval Hospital Guam is a significant milestone in neonatal healthcare. This innovative device not only embodies the company’s commitment to improving patient care but also highlights the importance of advanced medical technology in critical care settings.
